Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6521
    +0.0021 (+0.32%)
     
  • OIL

    82.86
    +0.05 (+0.06%)
     
  • GOLD

    2,332.50
    -5.90 (-0.25%)
     
  • Bitcoin AUD

    98,539.13
    -3,886.05 (-3.79%)
     
  • CMC Crypto 200

    1,392.04
    +9.47 (+0.68%)
     
  • AUD/EUR

    0.6080
    +0.0009 (+0.15%)
     
  • AUD/NZD

    1.0950
    +0.0008 (+0.07%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,244.58
    +43.31 (+0.25%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Why Shares of Repligen Rose This Week

Why Shares of Repligen Rose This Week

Shares of Repligen (NASDAQ: RGEN) were up 14.8% for the week late Thursday afternoon, according to S&P Global Market Intelligence. The healthcare company specializes in bioprocessing technology and creating solutions for the making of biologic drugs. It specializes in chromatography, filtration, and OEM products (proteins) and sells them to biopharmaceutical companies and contract development and manufacturing organizations.